Trial Profile
A real life study evaluating the efficacy and safety of Daclatasvir and Sofosbuvir with and without ribavirin in genotype 3 HCV-infected cirrhotic patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jul 2017
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 09 Jul 2017 New trial record